- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03811743
A Coordinated Parent/Child Dyad Weight Loss Intervention: Dyad Plus (Feasibility)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participation in this study will involve participation in six, one-hour sessions in addition to those required by your weight loss program. These sessions will work to facilitate an increase in self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs. Joint goal setting and tracking will be enabled by commercially available devices and apps. Each caregiver and child will receive an activity monitor, activity app, and a food app (digital food diary) that allows self-monitoring of consumption and "social accountability," which will allow caregivers and the Brenner FIT team to monitor and encourage. Furthermore, two home visits will be conducted to evaluation the home food and activity environments to inform tailored feedback to families.
Brenner FIT is a family-based pediatric weight management clinic for youth 2-18 years old referred by a physician for overweight or obesity.11-14 By Design is an adult (>18yrs) weight loss clinic that includes tailored dietary and physical activity behavioral counseling. The preliminary data suggest that most adolescent youth who enroll in Brenner FIT have at least one adult caregiver who is eligible and would benefit from enrollment in By Design Essentials.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Eligible for enrollment in Brenner FIT and/or By Design Essentials
- Caregiver who lives in the house with a BMI > 30
- No contraindication for physical activity or caloric restriction
- Must be able to read and write English
Exclusion Criteria:
- Over the age of 65
- BMI < 30
- Contraindication for physical activity or caloric restriction
- Cannot read or write English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Adolescents Participants
Adolescents will participate in the Dyad Plus program along with their caregivers.
The Dyad plus program consist of the combination of two existing programs (Brenner FIT for adolescents and By Design for the adult caregivers) with a new, novel coordination component
|
Brenner FIT pediatric weight management program enrollment.
an interdisciplinary, family-based pediatric weight management clinic based upon the Familial Approach to Treatment of Childhood Obesity.
Patients are referred by a physician for obesity or overweight with a weight-related comorbidity.
Treatment teams are comprised of a pediatrician, counselor, dietitian, and physical activity specialist, with others (e.g., social workers, physical therapists) as needed.
The entire family is encouraged to attend all aspects of the treatment program, although only one attending caregiver is required.
This component adds four additional strategies: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment. This innovative approach will seek to employ components of motivation and communication theories to increase self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs beyond gains observed in matched controls. Essentials (adults), with four additional components: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment |
Experimental: Caregivers of adolescents participants
Adult caregivers will participate in the Dyad Plus program along with their youth participants.
The Dyad plus program consist of the combination of two existing programs (Brenner FIT for adolescents and By Design for the adult caregivers) with a new, novel coordination component
|
This component adds four additional strategies: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment. This innovative approach will seek to employ components of motivation and communication theories to increase self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs beyond gains observed in matched controls. Essentials (adults), with four additional components: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment
Weight loss program for adults/caregivers of those enrolled in Brenner FIT.
Participants in the By Design condition (adult caregivers) will be prescribed the Essentials lifestyle intervention which includes tailored dietary and physical activity goals designed to achieve 1-2 lbs./week of weight loss, provided by a multidisciplinary team of medical providers, dietitians, behaviorists, and exercise specialists.
A daily calorie restriction of 500 kcal/day is prescribed based on estimates of total energy expenditure (TEE) obtained from a measured resting metabolic rate (RMR) prior to enrollment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BMI z-score
Time Frame: Baseline
|
Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits.
Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively).
BMI will be calculated as kg /m2.
BMI z-score will be calculated using CDC growth charts.
|
Baseline
|
BMI z-score
Time Frame: 6 months
|
Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits.
Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively).
BMI will be calculated as kg /m2.
BMI z-score will be calculated using CDC growth charts.
|
6 months
|
BMI z-score
Time Frame: 3 Months
|
Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits.
Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively).
BMI will be calculated as kg /m2.
BMI z-score will be calculated using CDC growth charts.
|
3 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Activity Assessed by Accelerometry
Time Frame: Baseline
|
Physical activity data will be collected using ActiGraph (trademark) accelerometers worn continuously over 7 days except during bathing and sleeping.
Moderate to vigorous activity will be measured in minutes.
|
Baseline
|
Physical Activity Assessed by Accelerometry
Time Frame: 6 months
|
Physical activity data will be collected using ActiGraph (trademark) accelerometers worn continuously over 7 days except during bathing and sleeping.
Moderate to vigorous activity will be measured in minutes.
|
6 months
|
Physical Activity Assessed by PAQ-A
Time Frame: Baseline
|
The Physical Activity Questionnaire for Adolescents (PAQ-A) will be given to assess physical activity. The PAQ-A ranges from 1-7. Higher score denotes better outcome. |
Baseline
|
Physical Activity Assessed by PAQ-A
Time Frame: 6 months
|
The Physical Activity Questionnaire for Adolescents (PAQ-A) will be given to assess physical activity. The PAQ-A ranges from 1-7. Higher score denotes better outcome. |
6 months
|
Physical Activity Assessed by IPAQ
Time Frame: Baseline
|
The International Physical Activity Questionnaire (IPAQ) will be given to assess physical activity in adults. The IPAQ ranges from 10-960 minutes/day of physical activity. Higher score denotes better outcome. |
Baseline
|
Physical Activity Assessed by IPAQ
Time Frame: 6 months
|
The International Physical Activity Questionnaire (IPAQ) will be given to assess physical activity in adults. The IPAQ ranges from 10-960 minutes/day of physical activity. Higher score denotes better outcome. |
6 months
|
Caloric intake expressed in kcals
Time Frame: Baseline
|
Diet will be assessed by the Automated Self-Administered 24-hour (ASA24) dietary assessment tool.
|
Baseline
|
Caloric intake expressed in kcals
Time Frame: 6 months
|
Diet will be assessed by the Automated Self-Administered 24-hour (ASA24) dietary assessment tool.
|
6 months
|
Concentration of fasting glucose for all participants, mg/dL
Time Frame: Baseline
|
Fasting blood glucose will be ascertained for each participant.
A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is optimal.
A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes.
|
Baseline
|
Concentration of fasting glucose for all participants, mg/dL
Time Frame: 6 months
|
Fasting blood glucose will be ascertained for each participant.
A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is optimal.
A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes.
|
6 months
|
Concentration of fasting Insulin for all participants, mg/dL
Time Frame: Baseline
|
Fasting insulin levels will be gathered from all participants.
|
Baseline
|
Concentration of fasting Insulin for all participants, mg/dL
Time Frame: 6 months
|
Fasting insulin levels will be gathered from all participants.
|
6 months
|
Hemoglobin A1c concentration for all participants, measured in percentage
Time Frame: 6 months
|
Normal range for the hemoglobin A1c level is between 4% and 5.6%.
Hemoglobin A1c levels between 5.7% and 6.4%.
Values greater denote diabetes.
|
6 months
|
Aspartate Aminotransferase -Levels of AST for all participants, measured in units per liter (IU/L)
Time Frame: Baseline
|
AST a useful test for detecting or monitoring liver damage.
|
Baseline
|
Aspartate Aminotransferase -Levels of AST for all participants, measured in units per liter (IU/L)
Time Frame: 6 months
|
AST a useful test for detecting or monitoring liver damage.
|
6 months
|
Alanine Aminotransferase-Levels of ALT for all participants, measured in units per liter
Time Frame: Baseline
|
A low level of ALT in the blood is expected and is normal.
|
Baseline
|
Alanine Aminotransferase-Levels of ALT for all participants, measured in units per liter
Time Frame: 6 months
|
A low level of ALT in the blood is expected and is normal.
|
6 months
|
Concentration of total cholesterol (mg/dL)
Time Frame: Baseline
|
total cholesterol: less than 200 mg/dL
|
Baseline
|
Concentration of total cholesterol (mg/dL)
Time Frame: 6 months
|
total cholesterol: less than 200 mg/dL
|
6 months
|
Hemoglobin A1c concentration for all participants, measured in percentage
Time Frame: Baseline
|
Normal range for the hemoglobin A1c level is between 4% and 5.6%.
Hemoglobin A1c levels between 5.7% and 6.4% Values greater denote diabetes.
|
Baseline
|
Economic costs of the three intervention arms over duration of program (USD)
Time Frame: Baseline through 6 months
|
Clinical and non-clinical costs of the interventions will be compiled over the duration of the program.
All cost will be reported in the same unit.
|
Baseline through 6 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00055004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Obesity
-
Virginia Commonwealth UniversityActive, not recruitingObesity, PediatricUnited States
-
University of British ColumbiaThe Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); Alberta Health services and other collaboratorsCompleted
-
Hasselt UniversityJessa HospitalCompletedObesity, Pediatric
-
Azienda Ospedaliera Universitaria Integrata VeronaNot yet recruitingObesity, Pediatric
-
University of British ColumbiaHeart and Stroke Foundation of Canada; Public Health Agency of Canada (PHAC); Childhood Obesity Foundation and other collaboratorsCompleted
-
Columbia UniversityCompletedVitamin D Deficiency | Obesity, Morbid | Obesity, Childhood | Obesity, PediatricUnited States
-
University Hospital, Clermont-FerrandAME2P Laboratory, Clermont Auvergne UniversityCompleted
-
Medical College of WisconsinWisconsin Department of Health and Family Services; Children's Health System...TerminatedPediatric Obesity | Pediatric OverweightUnited States
-
Kahramanmaras Sutcu Imam UniversityCompletedPediatric Obesity | Pediatric DentistryTurkey
-
Central Hospital, Nancy, FranceNot yet recruiting
Clinical Trials on Brenner FIT
-
Wake Forest University Health SciencesNational Institutes of Health (NIH)RecruitingPediatric Obesity | Weight Loss | Parent-Child Relations | Overweight Adolescents | Family and HouseholdUnited States
-
Wake Forest University Health SciencesCompletedParent-Child Relations | Obesity, Childhood | Weight Change, Body | Behavior, HealthUnited States
-
Whisper.aiSan Jose State UniversityRecruitingHearing LossUnited States
-
University of California, IrvineCompletedCardiovascular Diseases | Cardiovascular Risk FactorUnited States
-
University of Wisconsin, MadisonCompletedOverweightUnited States
-
Oregon Health and Science UniversityRecruitingAmyotrophic Lateral Sclerosis | Muscular Dystrophies | Spinal Cord Injuries | Multiple System Atrophy | Parkinson's Disease and Parkinsonism | Brain Tumor Adult | Locked-in Syndrome | Brainstem StrokeUnited States
-
University of Illinois at ChicagoNational Institute on Aging (NIA)CompletedOsteoarthritis | Overweight and ObesityUnited States
-
Manuel Gomez, MD, MSc.CompletedArthropathy of Knee JointCanada
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedColorectal Cancer
-
University Hospital, BrestRegistre des Tumeurs Digestives du Finistère; Centre Régional de Coordination...CompletedFemale | Colonoscopy | Occult Blood | Mass Screening | Early Detection of Cancer | Colorectal Neoplasms Malignant | Middle AgedFrance